gabexate has been researched along with Autoimmune Thrombocytopenia in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "She was diagnosed as idiopathic thrombocytopenic purpura and a standard dose of prednisolone was started immediately." | 1.29 | [Gabexate mesilate induced recovery from thrombocytopenia in a patient with acute ITP]. ( Ikeda, Y; Toyozumi, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyozumi, H | 1 |
| Ikeda, Y | 1 |
1 other study available for gabexate and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
[Gabexate mesilate induced recovery from thrombocytopenia in a patient with acute ITP].
Topics: Acute Disease; Complement Inactivator Proteins; Female; Gabexate; Gastrointestinal Hemorrhage; Human | 1996 |